Product information

Current status:

Cancelled (Unreturned Annual)

Current status date:

2024-01-08

Original market date: ^{See footnote 1}

Product name:

LIDOCAINE HCL INJECTION USP 1% (50 MG/5ML)

DIN:

02345048 Electronic product monograph is not available

Company:

4410602 CANADA INC
3524 Rue Ashby
St. Laurent
Quebec
Canada H4R 2C1

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Block/Infiltration

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

72:00.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

N01BB02 LIDOCAINE

Active ingredient group (AIG) number:^{See footnote5}

0101280004